Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.17812 | 48 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.11751 | 47 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.11413 | 47 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.01537 | 46 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.05513 | 47 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.26019 | 49 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.17361 | 47 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.10352 | 47 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.07365 | 47 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.07563 | 46 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.1112 | 47 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.04614 | 46 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.13207 | 48 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.11577 | 47 |